title: Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?
abstract: Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system; it might become the reference system in Asia. Transarterial chemoembolization (TACE) is the most widely used treatment for HCC worldwide; but it showed a benefit only for intermediate stage HCC (BCLC B), and there is still no consensus concerning treatment methods and treatment strategies. In view of the highly diverse nature of HCC and practices, a scoring system designed to assist with decision making before the first TACE is performed or prior to repeating the procedure would be highly useful.
authors.affiliation: Xavier Adhoute, Paul Castellani, Herve Perrier, Marc Bourliere, Department of Hepatology, Hopital Saint-Joseph, 13285 Marseille, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Adhoute
authors.affiliation: Xavier Adhoute, Paul Castellani, Herve Perrier, Marc Bourliere, Department of Hepatology, Hopital Saint-Joseph, 13285 Marseille, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Penaranda
authors.affiliation: Xavier Adhoute, Paul Castellani, Herve Perrier, Marc Bourliere, Department of Hepatology, Hopital Saint-Joseph, 13285 Marseille, France.
authors.forename: Paul
authors.initials: P
authors.lastname: Castellani
authors.affiliation: Xavier Adhoute, Paul Castellani, Herve Perrier, Marc Bourliere, Department of Hepatology, Hopital Saint-Joseph, 13285 Marseille, France.
authors.forename: Herve
authors.initials: H
authors.lastname: Perrier
authors.affiliation: Xavier Adhoute, Paul Castellani, Herve Perrier, Marc Bourliere, Department of Hepatology, Hopital Saint-Joseph, 13285 Marseille, France.
authors.forename: Marc
authors.initials: M
authors.lastname: Bourliere
keywords: Barcelona Clinic Liver Cancer; Hepatocellular carcinoma; Prognostic scoring systems; Transarterial chemoembolization
references.citation: Liver Int. 2004 Dec;24(6):625-9
references.pmid: 15566514
references.citation: Hepatology. 2003 Feb;37(2):429-42
references.pmid: 12540794
references.citation: Radiology. 2011 Feb;258(2):627-34
references.pmid: 21273524
references.citation: Eur J Radiol. 2012 Sep;81(9):2290-7
references.pmid: 21978775
references.citation: PLoS One. 2014 Jun 19;9(6):e100305
references.pmid: 24945380
references.citation: Gastroenterology. 2007 Jun;132(7):2557-76
references.pmid: 17570226
references.citation: Hepatology. 2013 Jun;57(6):2261-73
references.pmid: 23316013
references.citation: Gastroenterology. 2006 Aug;131(2):461-9
references.pmid: 16890600
references.citation: Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52
references.pmid: 19908093
references.citation: J Hepatol. 2014 Jan;60(1):118-26
references.pmid: 24012941
references.citation: Cancer. 2000 Jan 1;88(1):50-7
references.pmid: 10618605
references.citation: Dig Liver Dis. 2006 Feb;38(2):125-33
references.pmid: 16389002
references.citation: J Hepatol. 2011 Dec;55(6):1309-16
references.pmid: 21703196
references.citation: J Hepatol. 2012 Dec;57(6):1258-67
references.pmid: 22871502
references.citation: World J Gastroenterol. 2014 Jun 14;20(22):6995-7004
references.pmid: 24944494
references.citation: Lancet. 2012 Mar 31;379(9822):1245-55
references.pmid: 22353262
references.citation: Eur J Cancer. 2008 Mar;44(4):528-38
references.pmid: 18242076
references.citation: J Gastroenterol Hepatol. 2009 May;24(5):806-14
references.pmid: 19207681
references.citation: J Hepatol. 2012;56 Suppl 1:S75-87
references.pmid: 22300468
references.citation: Mol Biol Rep. 2014 Oct;41(10):6575-82
references.pmid: 25091939
references.citation: Hepatology. 2002 May;35(5):1164-71
references.pmid: 11981766
references.citation: Ann Oncol. 2013 Oct;24(10):2565-2570
references.pmid: 23857958
references.citation: Ann Surg Oncol. 2011 Feb;18(2):413-20
references.pmid: 20839057
references.citation: Gastroenterology. 2014 Jun;146(7):1691-700.e3
references.pmid: 24583061
references.citation: Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50
references.pmid: 15508101
references.citation: Hepatology. 2012 May;55(5):1432-42
references.pmid: 22109811
references.citation: Cancer Treat Rev. 2011 May;37(3):212-20
references.pmid: 20724077
references.citation: J Hepatol. 2015 Feb;62(2):492-3
references.pmid: 25194894
references.citation: Radiographics. 1998 May-Jun;18(3):605-19
references.pmid: 9599386
references.citation: Oncologist. 2010;15 Suppl 4:23-33
references.pmid: 21115578
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8
references.pmid: 21921256
references.citation: Semin Liver Dis. 2010 Feb;30(1):52-60
references.pmid: 20175033
references.citation: Radiology. 2012 May;263(2):590-9
references.pmid: 22438359
references.citation: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD004787
references.pmid: 21412886
references.citation: Radiology. 2002 Jul;224(1):47-54
references.pmid: 12091661
references.citation: J Hepatol. 2012 Jun;56(6):1330-5
references.pmid: 22314428
references.citation: Cancer. 2009 Feb 1;115(3):616-23
references.pmid: 19117042
references.citation: Gastroenterology. 2005 Jul;129(1):113-21
references.pmid: 16012941
references.citation: Ann Oncol. 2013 Jul;24(7):1786-1792
references.pmid: 23508822
references.citation: Hepatology. 2011 Dec;54(6):2238-44
references.pmid: 21932394
references.citation: Radiology. 1996 Jan;198(1):33-40
references.pmid: 8539401
references.citation: Lancet. 2002 May 18;359(9319):1734-9
references.pmid: 12049862
references.citation: BMC Gastroenterol. 2013 Apr 08;13:60
references.pmid: 23566041
references.citation: J Hepatol. 2012 Oct;57(4):821-9
references.pmid: 22727733
references.citation: J Hepatol. 2007 Mar;46(3):474-81
references.pmid: 17239480
references.citation: Clin Gastroenterol Hepatol. 2011 May;9(5):428-33; quiz e50
references.pmid: 21320639
references.citation: Oncology. 2011;81 Suppl 1:158-64
references.pmid: 22212951
references.citation: Eur J Cancer. 2013 Mar;49(4):826-34
references.pmid: 22995582
references.citation: Lancet. 2003 Dec 6;362(9399):1907-17
references.pmid: 14667750
references.citation: Hepatology. 2014 Jun;59(6):2424-5
references.pmid: 24114720